Company · CIK 0001560241 · SIC 2834 — Pharmaceutical Preparations
G1 Therapeutics, Inc. · GTHX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2018 MForm 4 → | Jan 17, 9:48 am EST | Mark A. VellecaPresident and CEO, Director | 7,500 | $3.72 | $27,900 | 7,500 | — | plan? |
| Jan 16, 2018 SForm 4 → | Jan 17, 9:47 am EST | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | $22.96 | $86,693 | 0 | −100% | plan? |
| Jan 16, 2018 MForm 4 → | Jan 17, 9:47 am EST | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | $0.30 | $1,133 | 3,776 | — | plan? |
| Jan 5, 2018 SForm 4 → | Jan 8, 9:42 am EST | Jennifer K. MosesVP of Finance & Admin | 750 | $19.96 | $14,970 | 0 | −100% | plan? |
| Jan 5, 2018 MForm 4 → | Jan 8, 9:42 am EST | Jennifer K. MosesVP of Finance & Admin | 750 | $0.39 | $293 | 750 | — | plan? |
| Dec 18, 2017 SForm 4 → | Dec 20, 8:48 am EST | Mark A. VellecaPresident and CEO, Director | 7,500 | $20.01 | $150,106 | 0 | −100% | plan? |
| Dec 18, 2017 MForm 4 → | Dec 20, 8:48 am EST | Mark A. VellecaPresident and CEO, Director | 7,500 | $3.72 | $27,900 | 7,500 | — | plan? |
| Dec 15, 2017 SForm 4 → | Dec 18, 5:48 pm EST | MedImmune Ventures, Inc.10% Owner | 200,000 | $19.75 | $3,950,000 | 2,950,630 | −6.35% | plan? |
| Dec 1, 2017 SForm 4 → | Dec 5, 9:17 am EST | MedImmune Ventures, Inc.10% Owner | 133,906 | $19.75 | $2,644,644 | 3,150,630 | −4.08% | plan? |
| Nov 30, 2017 JForm 4 → | Dec 4, 5:06 pm EST | Christy L ShafferDirector | 100,508 | — | — | 995 | — | plan? |
| Nov 30, 2017 JForm 4 → | Dec 4, 5:01 pm EST | Clay Thorp +610% Owner | 100,508 | — | — | 4,075,211 | — | plan? |
| Nov 20, 2017 SForm 4 → | Nov 22, 10:13 am EST | MedImmune Ventures, Inc.10% Owner | 200,000 | $20.01 | $4,002,000 | 3,284,536 | −5.74% | plan? |
| Nov 13, 2017 PForm 4 → | Nov 15, 5:12 pm EST | Fredric N EshelmanDirector, 10% Owner | 250,000 | $19.73 | $4,932,500 | 250,000 | — | plan? |
| May 22, 2017 PForm 4 → | May 24, 8:29 pm EDT | Eshelman Ventures, LLC10% Owner | 300,000 | $15.00 | $4,500,000 | 3,439,151 | +9.56% | plan? |
| May 22, 2017 CForm 4 → | May 24, 8:29 pm EDT | Eshelman Ventures, LLC10% Owner | 3,139,151 | — | — | 3,139,151 | — | plan? |
| May 22, 2017 PForm 4 → | May 24, 8:18 pm EDT | Clay Thorp +610% Owner | 133,333 | $15.00 | $1,999,995 | 3,861,797 | +3.58% | plan? |
| May 22, 2017 CForm 4 → | May 24, 8:18 pm EDT | Clay Thorp +610% Owner | 4,040,396 | — | — | 99,513 | — | plan? |
| May 22, 2017 PForm 4 → | May 24, 8:05 pm EDT | Fredric N EshelmanDirector, 10% Owner | 300,000 | $15.00 | $4,500,000 | 3,439,151 | +9.56% | plan? |
| May 22, 2017 CForm 4 → | May 24, 8:05 pm EDT | Fredric N EshelmanDirector, 10% Owner | 3,139,151 | — | — | 3,139,151 | — | plan? |
| May 22, 2017 CForm 4 → | May 24, 8:02 pm EDT | Jay StrumChief Scientific Officer | 16,666 | — | — | 58,569 | — | plan? |
| May 22, 2017 CForm 4 → | May 24, 7:59 pm EDT | Christy L ShafferDirector | 99,513 | — | — | 99,513 | — | plan? |
| May 22, 2017 CForm 4 → | May 24, 7:58 pm EDT | Seth RudnickDirector | 2,757 | — | — | 58,282 | — | plan? |
| May 22, 2017 PForm 4 → | May 24, 7:58 pm EDT | Glenn P MuirDirector | 20,000 | $15.00 | $300,000 | 120,969 | +19.8% | plan? |
| May 22, 2017 CForm 4 → | May 24, 7:58 pm EDT | Glenn P MuirDirector | 100,969 | — | — | 100,969 | — | plan? |
| May 22, 2017 PForm 4 → | May 24, 7:57 pm EDT | MedImmune Ventures, Inc.10% Owner | 75,000 | $15.00 | $1,125,000 | 3,484,536 | +2.20% | plan? |
| May 22, 2017 CForm 4 → | May 24, 7:57 pm EDT | MedImmune Ventures, Inc.10% Owner | 3,409,536 | — | — | 3,409,536 | — | plan? |
| May 22, 2017 PForm 4 → | May 24, 4:34 pm EDT | RA CAPITAL MANAGEMENT, LLC +2Other | 400,000 | $15.00 | $6,000,000 | 2,684,244 | +17.5% | plan? |
| May 22, 2017 CForm 4 → | May 24, 4:34 pm EDT | RA CAPITAL MANAGEMENT, LLC +2Other | 2,284,244 | — | — | 2,284,244 | — | plan? |
| May 17, 2017 PForm 4/A → | Dec 13, 11:46 am EST | MedImmune Ventures, Inc.10% Owner | 75,000 | $15.00 | $1,125,000 | 3,409,536 | +2.25% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2019 MForm 4 → | Jan 28, 9:10 pm EST | Rajesh MalikCh. Medical Officer & SVP R&D | 7,000 | — | — | 90,444 | — | |
| Jan 17, 2019 MForm 4 → | Jan 17, 5:52 pm EST | Jennifer K. MosesVP of Finance | 2,000 | — | — | 8,333 | — | |
| Jan 17, 2019 MForm 4 → | Jan 17, 5:52 pm EST | Mark A. VellecaPresident and CEO, Director | 9,000 | — | — | 380,286 | — | |
| Jan 2, 2019 AMForm 4 → | Jan 2, 5:46 pm EST | Jay StrumChief Scientific Officer | 94,818 | — | — | 0 | — | |
| Jan 2, 2019 AForm 4 → | Jan 2, 5:32 pm EST | Jennifer K. MosesVP of Finance | 20,000 | — | — | 20,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 2, 5:29 pm EST | James S. HansonGeneral Counsel | 60,000 | — | — | 60,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 2, 5:29 pm EST | Barclay A PhillipsSVP & Chief Financial Officer | 60,000 | — | — | 60,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 2, 5:29 pm EST | Terry L MurdockChief Operating Officer | 60,000 | — | — | 60,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 2, 5:29 pm EST | Rajesh MalikCh. Medical Officer & SVP R&D | 60,000 | — | — | 60,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 2, 5:28 pm EST | John DemareeChief Commercial Officer | 60,000 | — | — | 60,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 2, 5:28 pm EST | Mark A. VellecaPresident and CEO, Director | 225,000 | — | — | 225,000 | — | |
| Dec 17, 2018 MForm 4 → | Dec 17, 4:27 pm EST | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 65,519 | — | |
| Dec 6, 2018 MForm 4 → | Dec 7, 4:07 pm EST | Jennifer K. MosesVP of Finance & Admin | 2,750 | — | — | 10,333 | — | |
| Dec 4, 2018 MForm 4 → | Dec 4, 6:10 pm EST | Seth RudnickDirector | 10,000 | — | — | 7,969 | — | |
| Dec 3, 2018 MForm 4 → | Dec 3, 6:25 pm EST | Terry L MurdockSVP of Development Operations | 3,523 | — | — | 82,401 | — | |
| Nov 15, 2018 MForm 4 → | Nov 16, 7:16 pm EST | Barclay A PhillipsSVP & Chief Financial Officer | 5,000 | — | — | 95,000 | — | |
| Nov 15, 2018 MForm 4 → | Nov 16, 5:17 pm EST | Mark A. VellecaPresident and CEO, Director | 5,000 | — | — | 119,433 | — | |
| Nov 15, 2018 MForm 4 → | Nov 16, 5:17 pm EST | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 69,295 | — | |
| Nov 5, 2018 MForm 4 → | Nov 7, 6:18 pm EST | Seth RudnickDirector | 10,000 | — | — | 607 | — | |
| Nov 5, 2018 MForm 4 → | Nov 7, 6:18 pm EST | Terry L MurdockSVP of Development Operations | 3,519 | — | — | 85,924 | — | |
| Nov 5, 2018 MForm 4 → | Nov 7, 6:15 pm EST | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 2,416 | — | |
| Oct 15, 2018 MForm 4 → | Oct 15, 5:57 pm EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 10,076 | — | — | 97,444 | — | |
| Oct 11, 2018 MForm 4 → | Oct 15, 5:54 pm EDT | Mark A. VellecaPresident and CEO, Director | 15,000 | — | — | 124,433 | — | |
| Oct 8, 2018 MForm 4 → | Oct 10, 4:45 pm EDT | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 3,166 | — | |
| Oct 4, 2018 MForm 4 → | Oct 5, 6:04 pm EDT | Jay StrumChief Scientific Officer | 850 | — | — | 15,816 | — | |
| Oct 4, 2018 MForm 4 → | Oct 5, 6:02 pm EDT | Seth RudnickDirector | 10,000 | — | — | 10,607 | — | |
| Oct 3, 2018 MForm 4 → | Oct 5, 6:02 pm EDT | Terry L MurdockSVP of Development Operations | 3,519 | — | — | 89,443 | — | |
| Sep 17, 2018 MForm 4 → | Sep 19, 7:08 pm EDT | Mark A. VellecaPresident and CEO, Director | 5,000 | — | — | 129,433 | — | |
| Sep 17, 2018 MForm 4 → | Sep 19, 7:07 pm EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 76,847 | — | |
| Sep 12, 2018 AForm 4 → | Sep 13, 4:10 pm EDT | Garry A NicholsonDirector | 20,000 | — | — | 20,000 | — | |
| Sep 5, 2018 MForm 4 → | Sep 6, 4:07 pm EDT | Jennifer K. MosesVP of Finance & Admin | 2,750 | — | — | 3,916 | — | |
| Sep 4, 2018 MForm 4 → | Sep 6, 4:07 pm EDT | Seth RudnickDirector | 10,000 | — | — | 20,607 | — | |
| Sep 4, 2018 MForm 4 → | Sep 6, 4:06 pm EDT | Terry L MurdockSVP of Development Operations | 3,519 | — | — | 92,962 | — | |
| Aug 15, 2018 MForm 4 → | Aug 17, 3:00 pm EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 80,623 | — | |
| Aug 15, 2018 MForm 4 → | Aug 17, 2:59 pm EDT | Mark A. VellecaPresident and CEO, Director | 5,000 | — | — | 134,433 | — | |
| Aug 6, 2018 MForm 4 → | Aug 6, 6:19 pm EDT | Seth RudnickDirector | 10,000 | — | — | 30,607 | — | |
| Aug 6, 2018 MForm 4 → | Aug 6, 6:18 pm EDT | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 4,666 | — | |
| Aug 3, 2018 MForm 4 → | Aug 6, 6:17 pm EDT | Terry L MurdockSVP of Development Operations | 3,519 | — | — | 96,481 | — | |
| Jul 16, 2018 MForm 4 → | Jul 17, 4:01 pm EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 84,399 | — | |
| Jul 16, 2018 MForm 4 → | Jul 17, 4:01 pm EDT | Mark A. VellecaPresident and CEO, Director | 5,000 | — | — | 139,433 | — | |
| Jul 5, 2018 MForm 4 → | Jul 5, 3:21 pm EDT | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 5,416 | — | |
| Jul 3, 2018 AForm 4 → | Jul 6, 4:47 pm EDT | John DemareeChief Commercial Officer | 225,000 | — | — | 225,000 | — | |
| Jun 25, 2018 AForm 4 → | Jun 27, 4:08 pm EDT | James S. HansonGeneral Counsel | 140,000 | — | — | 140,000 | — | |
| Jun 15, 2018 MForm 4 → | Jun 18, 10:19 am EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 88,175 | — | |
| Jun 8, 2018 MForm 4 → | Jun 11, 10:51 am EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 4,200 | — | — | 103,744 | — | |
| Jun 7, 2018 AForm 4 → | Jun 11, 12:18 pm EDT | Andrew WittyDirector | 10,000 | — | — | 10,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 11, 12:13 pm EDT | Glenn P MuirDirector | 10,000 | — | — | 10,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 11, 12:04 pm EDT | Fredric N EshelmanDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 11, 11:59 am EDT | Seth RudnickDirector | 10,000 | — | — | 10,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 11, 11:52 am EDT | Cynthia SchwalmDirector | 20,000 | — | — | 20,000 | — | |
| Jun 7, 2018 AForm 4 → | Jun 11, 11:47 am EDT | Willie A DeeseDirector | 20,000 | — | — | 20,000 | — | |
| Jun 5, 2018 MForm 4 → | Jun 5, 2:23 pm EDT | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 6,166 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 2:35 pm EDT | Terry L MurdockSVP of Development Operations | 50,000 | — | — | 50,000 | — | |
| May 31, 2018 MForm 4 → | May 31, 4:22 pm EDT | Mark A. VellecaPresident and CEO, Director | 10,000 | — | — | 399,286 | — | |
| May 15, 2018 MForm 4 → | May 16, 1:37 pm EDT | Mark A. VellecaPresident and CEO, Director | 7,500 | — | — | 144,433 | — | |
| May 15, 2018 MForm 4 → | May 16, 1:37 pm EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 91,951 | — | |
| May 7, 2018 MForm 4 → | May 7, 3:04 pm EDT | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 250 | — | |
| Apr 16, 2018 MForm 4 → | Apr 17, 12:20 pm EDT | Mark A. VellecaPresident and CEO, Director | 7,500 | — | — | 151,933 | — | |
| Apr 16, 2018 MForm 4 → | Apr 17, 12:20 pm EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 95,727 | — | |
| Apr 5, 2018 MForm 4 → | Apr 5, 4:04 pm EDT | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 1,000 | — | |
| Mar 15, 2018 MForm 4 → | Mar 16, 10:09 am EDT | Mark A. VellecaPresident and CEO, Director | 7,500 | — | — | 159,433 | — | |
| Mar 15, 2018 MForm 4 → | Mar 16, 10:09 am EDT | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 0 | — | |
| Mar 8, 2018 MForm 4 → | Mar 9, 2:36 pm EST | Rajesh MalikCh. Medical Officer & SVP R&D | 4,200 | — | — | 107,944 | — | |
| Mar 5, 2018 MForm 4 → | Mar 6, 4:01 pm EST | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 1,750 | — | |
| Feb 15, 2018 MForm 4 → | Feb 16, 11:54 am EST | Mark A. VellecaPresident and CEO, Director | 7,500 | — | — | 166,933 | — | |
| Feb 15, 2018 MForm 4 → | Feb 16, 11:54 am EST | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 0 | — | |
| Feb 5, 2018 MForm 4 → | Feb 6, 11:00 am EST | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 2,500 | — | |
| Jan 16, 2018 MForm 4 → | Jan 17, 9:48 am EST | Mark A. VellecaPresident and CEO, Director | 7,500 | — | — | 174,433 | — | |
| Jan 16, 2018 MForm 4 → | Jan 17, 9:47 am EST | Rajesh MalikCh. Medical Officer & SVP R&D | 3,776 | — | — | 2,890 | — | |
| Jan 5, 2018 MForm 4 → | Jan 8, 9:42 am EST | Jennifer K. MosesVP of Finance & Admin | 750 | — | — | 3,250 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 9:40 am EST | Mark A. VellecaPresident and CEO, Director | 75,000 | — | — | 75,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 9:40 am EST | Rajesh MalikCh. Medical Officer & SVP R&D | 50,000 | — | — | 50,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 9:40 am EST | Jay StrumChief Scientific Officer | 25,000 | — | — | 25,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 9:40 am EST | Terry L MurdockSVP of Development Operations | 50,000 | — | — | 50,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 9:40 am EST | Jennifer K. MosesVP of Finance & Admin | 25,000 | — | — | 25,000 | — | |
| Dec 18, 2017 MForm 4 → | Dec 20, 8:48 am EST | Mark A. VellecaPresident and CEO, Director | 7,500 | — | — | 181,933 | — | |
| Dec 6, 2017 AForm 4 → | Dec 6, 6:21 pm EST | Barclay A PhillipsSVP & Chief Financial Officer | 250,000 | — | — | 250,000 | — | |
| Aug 1, 2017 AForm 4 → | Aug 3, 5:42 pm EDT | Terry L MurdockSVP of Development Operations | 100,000 | — | — | 100,000 | — | |
| Jul 11, 2017 AForm 4 → | Jul 13, 7:41 pm EDT | Glenn P MuirDirector | 20,000 | — | — | 20,000 | — | |
| Jul 11, 2017 AForm 4 → | Jul 13, 7:41 pm EDT | Fredric N EshelmanDirector, 10% Owner | 20,000 | — | — | 20,000 | — | |
| Jul 11, 2017 AForm 4 → | Jul 13, 7:39 pm EDT | Seth RudnickDirector | 20,000 | — | — | 20,000 | — | |
| Jul 11, 2017 AForm 4 → | Jul 13, 7:39 pm EDT | Christy L ShafferDirector | 20,000 | — | — | 20,000 | — | |
| Jul 11, 2017 AForm 4 → | Jul 13, 7:35 pm EDT | Andrew WittyDirector | 20,000 | — | — | 20,000 | — | |
| May 22, 2017 CForm 4 → | May 24, 8:29 pm EDT | Eshelman Ventures, LLC10% Owner | 9,417,457 | — | — | 0 | — | |
| May 22, 2017 CForm 4 → | May 24, 8:18 pm EDT | Clay Thorp +610% Owner | 11,481,860 | — | — | 0 | — | |
| May 22, 2017 CForm 4 → | May 24, 8:05 pm EDT | Fredric N EshelmanDirector, 10% Owner | 9,417,457 | — | — | 0 | — | |
| May 22, 2017 CForm 4 → | May 24, 8:02 pm EDT | Jay StrumChief Scientific Officer | 50,000 | — | — | 0 | — | |
| May 22, 2017 CForm 4 → | May 24, 7:59 pm EDT | Christy L ShafferDirector | 298,543 | — | — | 0 | — | |
| May 22, 2017 CForm 4 → | May 24, 7:58 pm EDT | Seth RudnickDirector | 8,271 | — | — | 0 | — | |
| May 22, 2017 CForm 4 → | May 24, 7:58 pm EDT | Glenn P MuirDirector | 302,908 | — | — | 0 | — | |
| May 22, 2017 CForm 4 → | May 24, 7:57 pm EDT | MedImmune Ventures, Inc.10% Owner | 10,228,613 | — | — | 0 | — | |
| May 22, 2017 CForm 4 → | May 24, 4:34 pm EDT | RA CAPITAL MANAGEMENT, LLC +2Other | 6,852,738 | $1.82 | $12,499,998 | 0 | — |